These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32927725)

  • 21. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
    Ghosh S; Banerjee S; Sil PC
    Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced Water Dispersibility of Curcumin Encapsulated in Alginate-Polysorbate 80 Nano Particles and Bioavailability in Healthy Human Volunteers.
    Govindaraju R; Karki R; Chandrashekarappa J; Santhanam M; Shankar AKK; Joshi HK; Divakar G
    Pharm Nanotechnol; 2019; 7(1):39-56. PubMed ID: 30666922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
    Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
    Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent updates in curcumin delivery.
    Obeid MA; Alsaadi M; Aljabali AA
    J Liposome Res; 2023 Mar; 33(1):53-64. PubMed ID: 35699160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Stati G; Rossi F; Sancilio S; Basile M; Di Pietro R
    Front Pharmacol; 2021; 12():780330. PubMed ID: 34776989
    [No Abstract]   [Full Text] [Related]  

  • 30. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
    Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
    [No Abstract]   [Full Text] [Related]  

  • 31. Dietary Curcumin: Correlation between Bioavailability and Health Potential.
    Dei Cas M; Ghidoni R
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin, a Compound from Natural Sources, a True Scientific Challenge - A Review.
    Stanić Z
    Plant Foods Hum Nutr; 2017 Mar; 72(1):1-12. PubMed ID: 27995378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.
    Khosravi MA; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3477-3491. PubMed ID: 37966571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental Strategies of Curcumin Solid Dispersions for Enhancing Bioavailability.
    Tran PHL; Tran TTD
    Anticancer Agents Med Chem; 2020; 20(16):1874-1882. PubMed ID: 32640962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic roles of curcumin: lessons learned from clinical trials.
    Gupta SC; Patchva S; Aggarwal BB
    AAPS J; 2013 Jan; 15(1):195-218. PubMed ID: 23143785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline.
    Gupta NK; Dixit VK
    J Pharm Sci; 2011 May; 100(5):1987-95. PubMed ID: 21374628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin therapeutic promises and bioavailability in colorectal cancer.
    Shehzad A; Khan S; Shehzad O; Lee YS
    Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
    Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
    J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular understanding of curcumin in diabetic nephropathy.
    Soetikno V; Suzuki K; Veeraveedu PT; Arumugam S; Lakshmanan AP; Sone H; Watanabe K
    Drug Discov Today; 2013 Aug; 18(15-16):756-63. PubMed ID: 23651956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders.
    Yavarpour-Bali H; Ghasemi-Kasman M; Pirzadeh M
    Int J Nanomedicine; 2019; 14():4449-4460. PubMed ID: 31417253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.